RESEARCH GROUPS

Neuroradiology

Overview

Team

Publications

Projects

Patents

Dissemination

50

Number of publications

78.00
%

% Q1

32.00
%

% D1

70.00
%

% Leadership

34.29
%

% Female Leadership

3.41

CROWN (2021-2025)

31.52
%

HCP10% (2021-2025)

58.00
%

% Open access

52.00
%

% International Collaboration

11

Highly cited papers / HCP 1% (2021-2025)

3

Publications in high-IF journals with high Altmetric scores

2

Number of Ongoing Projectes (total)

0

International ongoing projects

0

Number of New projects (total)

0

International new projects

0

Number of Active clinical Trials

0

Number of New Clinical Trials

0

Number of Theses

In 2025, our work reinforced the clinical value of magnetic resonance imaging (MRI) in neuroradiology, with a particular focus on supporting everyday decision-making. We led the MAGNIMS-CMSC-NAIMS international consensus on the implementation of MRI in the 2024 revision of the McDonald diagnostic criteria for multiple sclerosis, with special emphasis on the integration of optic nerve imaging and emerging biomarkers such as the central vein sign and paramagnetic rim lesions. In the field of neuro-oncology, we contributed to recommendations on the use of gadolinium-based contrast agents, promoting a more selective and indication-driven approach to contrast administration. Finally, in collaboration with IDI Bellvitge, we explored how quantitative imaging, radiomics, and artificial intelligence can be effectively integrated into clinical neuroradiology, with a focus on bridging technical innovation with real clinical needs.

CORE/MISSIONS

  • AI, Data, Imaging & Digital Health

PROGRAMS

TEAM

Group Leader

Àlex Rovira

Principal Investigator (PI)

Deborah Pareto

Researchers

Carlos Tortajada, Cristina Auger, Silvana Sarria, Margareta Clarke, Elvira García Guzmán, Frederic-Vicenç Sampedro Santaló

SELECTED PUBLICATIONS

Barkhof F, Reich DS, Oh J, Rocca MA, Li DKB, Sati P, Azevedo CJ, Bagnato F, Calabresi PA, Ciccarelli O, Dwyer MG, DeLuca GC, De Stefano N, Enzinger C, Filippi M, Granziera C, Halper J, Henry RG, Gasperini C, Gauthier S, Kappos L, Laule C, Newsome SD, Montalban X, Morrow SA, Schoonheim MM, Sicotte N, Toosy A, Wilken J, Yousry T, Sastre-Garriga J, Traboulsee A, Ontaneda D, Rovira À
Cooperative MRI guidelines working group. 2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
Lancet Neurol. 2025 Oct;24(10):866-879
DOI: 10.1016/S1474-4422(25)00304-7
IF: 56.2

Ajdinaj P, Mongay-Ochoa N, Alberich M, Tintore M, Montalban X, Rovira À, Pareto D, Sastre-Garriga J.
Long-term impact of spinal cord reserve on disability accumulation in multiple sclerosis.
Mult Scler. 2025 Oct;31(12):1483-1492
DOI: 10.1177/13524585251378995
IF: 5.0

Doniselli FM, Ramos J, Hilario A, Opancina V, van der Hoorn A, Castellano A, van der Molen AJ, Quattrocchi CC, Yousry T, Rovira À
Recommendations on the use of gadolinium-based contrast agents in the diagnosis and monitoring of common adult intracranial tumours.
Eur Radiol. 2025 Dec;35(12):7774-7785
DOI: 10.1007/s00330-025-11646-6
IF: 4.7

Pareto D, Naval-Baudin P, Pons-Escoda A, Bargalló N, Garcia-Gil M, Majós C, Rovira À
Image analysis research in neuroradiology: bridging clinical and technical domains
Neuroradiology. 2025 Jul;67(7):1649-1666
DOI: 10.1007/s00234-025-03633-x
IF: 2.6

Cappelle S, Verbraeken V, Demaerel P, Rovira A, Pareto D
The value of manual MRI measurements of brain and spinal cord for daily clinical practice in multiple sclerosis subjects: A scoping review
Mult Scler Relat Disord. 2025 Nov;103:106670
DOI: 10.1016/j.msard.2025.106670
IF: 5.5

SELECTED PROJECTS

Characterization of disability and cognition in people with multiple sclerosis from conventional magnetic resonance imaging (PI22/01709)
Principal Investigator: Deborah Pareto
Agency: Instituto de Salud Carlos III
Funding: 87,120€
Period: 2023-2025

Structural and functional characterization of the anterior visual pathway in people with multiple sclerosis (PI22/01589)
Principal Investigator: Angela Vidal / Àlex Rovira
Agency: Instituto de Salud Carlos III
Funding: 48,400€
Period: 2023-2025

MR imaging of the optic nerve: assessment of sensitivity and reproducibility of different MR sequences
Principal Investigator: Àlex Rovira
Agency: N/A
Funding: N/A
Period: 2022-2025

Difuse involvement of the corticospinal tract in multiple sclerosis on DIR images: association with clinical and MRI measures
Principal Investigator: Àlex Rovira
Agency: N/A
Funding: N/A
Period: 2022-2025

Study of functional brain magnetic resonance in patients with psoriasis arthritis and psoriasis treated with targeted therapies. / Estudio de resonancia magnética funcional cerebral en pacientes con artritis psoriásica y psoriasis tratados con terápias dirigidas. (BREFPOD).
Principal Investigator: Sara Marsal
Agency: ASPIRE Pfizer
Funding: N/A
Period: 2022-2025

PATENTS

DISSEMINATION ACTIVITIES